FindTrial
Sign In

A Mobile App to Help DCLD patient monitoring Their Health, Medications, Recovery, and Quality of Life

Integrated mobile health management system in patient with Decompensated liver disease for monitoring disease progression , Drug compliance , Rehabilitation and quality of life improvement through mobile application - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082162
Enrollment
100
Registered
2025-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R188- Other ascites

Interventions

Intervention1: Mobile application users Arm: Patients in this arm will receive the Integrated Mobile Health Management System, a mobile application designed specifically for patients with Decompensate

Sponsors

SAVEETHA MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirmed diagnosis of decompensated liver disease 2. Adults aged 18-75 years. 3. Possession and ability to use a compatible smartphone or tablet. 4. Willingness to provide informed consent and comply with study protocols. 5. Clinically stable condition as assessed by a healthcare provider. 6. Understanding of either English or Tamil.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment or psychiatric disorders preventing effective app usage. 2. Lack of access to a compatible smartphone or tablet. 3. Inability to read or understand English or Tamil, without a reliable bystander to assist. 4. Clinically unstable patients without a reliable bystander to assist with app usage. 5. History of non-compliance with medical treatment or follow-up appointments. 6. Age outside the range of 18-75 years.

Design outcomes

Primary

MeasureTime frame
Better symptom management and alert tracking. Slowed disease progression. Reduced complications and readmissions. Improved survival and quality of life.Timepoint: Period for analysing the data : 3 months—

Secondary

MeasureTime frame
Enhanced drug compliance. Effective end-of-life care and palliation.Timepoint: app follow up till death—

Countries

India

Contacts

Public ContactRam Kumar

Saveetha Medical College and Hospital

docramk444@gmail.com9976416171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026